AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PRO MEDICUS LTD

229.410

+4.8502.16%

Volume:254.58K

Turnover:58.15M

Market Cap:23.96B

PE:244.21

High:229.410

Open:224.560

Low:222.220

Close:224.560

Loading ...

Overview Company News Filings

3 founder-led ASX 200 shares with serious long-term upside

This is the number one factor I look for when buying ASX dividend shares

3 ASX 200 stocks to buy and hold forever without thinking twice

3 oversold ASX shares begging to rebound

Warren Buffett's warning to markets played out perfectly: the time to be greedy may be approaching

Telix: A masterclass in what this game is all about

Down 9% in a month! The ASX200 growth stock I'm watching

High Growth Tech Stocks in Australia Including FINEOS Corporation Holdings

Simply Wall St.

2 great ASX growth shares that are much cheaper after the market sell-off

Down 20% to 40%: These oversold ASX shares could be bargains hiding in plain sight

Is Weakness In Pro Medicus Limited (ASX:PME) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Simply Wall St.

Now could be a golden opportunity to buy these ASX 200 growth shares

How to build the perfect ASX share portfolio

3 of the best ASX 200 healthcare shares to bring your portfolio to life

Shareholders May Not Overlook Pro Medicus Insiders Selling AU$514m In Stock

Simply Wall St.

Pro Medicus inks R&D agreement with UCSF for Visage AI Accelerator

The Market Herald

Pro Medicus Unit Signs Multi-Year Research Collaboration Agreement for AI Accelerator Platform

MT Newswires Live

BRIEF-Pro Medicus Signs Multi-Year Research Collaboration Agreement With UCSF

Pro Medicus shares rise on big AI news

Pro Medicus Ltd - Pme Signs Multi-Year Research Collaboration Agreement With Ucsf

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PME.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PME.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","market":"AU","secType":"STK","nameCN":"PRO MEDICUS LTD","latestPrice":229.41,"timestamp":1745993520000,"preClose":224.56,"halted":0,"volume":254584,"delay":0,"nameEN":"PRO MEDICUS LTD","floatShares":52960584,"shares":104462909,"eps":0.939404,"marketStatus":"Not Yet Opened","change":4.85,"latestTime":"04-30 16:12:00 AEST","open":224.56,"high":229.41,"low":222.22,"amount":58149483,"amplitude":0.032018,"askPrice":230,"askSize":535,"bidPrice":228.62,"bidSize":21,"shortable":3,"etf":0,"ttmEps":0.939404,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":224.56,"dividendRate":0.002049,"openAndCloseTimeList":[[1745971200000,1745992800000]],"volumeRatio":1.011202,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","floatShares":52960584,"roa":"32.90%","roe":"51.53%","lyrEps":0.792737,"volumeRatio":1.011202,"shares":104462909,"dividePrice":0.47,"high":229.41,"amplitude":0.032018,"preClose":224.56,"low":222.22,"week52Low":108.932,"pbRate":"107.83","psRate":"129.83","week52High":298.706,"institutionHeld":0,"latestPrice":229.41,"committee":-0.92446,"eps":0.939404,"divideRate":0.002049,"volume":254584,"delay":0,"ttmEps":0.939404,"open":224.56,"prevYearClose":249.891,"prevWeekClose":210.78,"prevMonthClose":199.79,"prevQuarterClose":199.79,"fiveDayClose":205.33,"twentyDayClose":201.8,"sixtyDayClose":278.145},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PME.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531353728","title":"3 founder-led ASX 200 shares with serious long-term upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2531353728","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531353728?lang=en_us&edition=fundamental","pubTime":"2025-04-30 09:45","pubTimestamp":1745977500,"startTime":"0","endTime":"0","summary":"One of the most powerful — yet often overlooked — traits in a great company is founder leadership. Founders tend to think differently. They are often more committed to long-term vision over short-term","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/3-founder-led-asx-200-shares-with-serious-long-term-upside/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4504","BK4127","BK4552","LU0251142724.SGD","BK7510","LU1868836757.USD","LU2471134952.CNY","LU2237443382.USD","LU1791807156.HKD","BK7155","BK4516","LU0048573561.USD","BK4550","LU1868836591.USD","LU2750360997.AUD","IE0034235188.USD","LU1868837136.USD","LU2471134523.USD","PME.AU","LU2237443622.USD","LU2237438978.USD","BK4585","BK4588","LU2471134879.HKD","LU2237443549.SGD","GMG.AU","LU1868836914.USD","BK7016","IE00BFXG1179.USD","LU2237443465.HKD","IE00BSNM7G36.USD","LU1868837300.USD","LU0061475181.USD","LU2237443978.SGD","BK4613","LU0742534661.SGD","LU1668664300.SGD","LU2471134796.USD","360.AU","IE00B19Z3B42.SGD","LU0096364046.USD","LU2237443895.HKD","LIF","IE00B19Z3581.USD","LU0106831901.USD","BK7099","IE0004086264.USD","IE0002270589.USD","BK7094","LU0251131958.USD"],"gpt_icon":0},{"id":"2531108157","title":"This is the number one factor I look for when buying ASX dividend shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2531108157","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531108157?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:30","pubTimestamp":1745969400,"startTime":"0","endTime":"0","summary":"ASX dividend shares can be great investments. However, there's a particular factor that I look for the most when it comes to passive income.  When it comes to businesses that paydividends, there are various elements to consider. How big is the dividend yield?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/this-is-the-number-one-factor-i-look-for-when-buying-asx-dividend-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SHL.AU","WBC.AU","FMG.AU","BK7105","TNE.AU","BK7503","BK7016","BK7507","BKW.AU","COL.AU","PME.AU","NAB.AU","BK7501","BK7044","ANZ.AU","BK7083","WTC.AU","BK7095","BK7135","BHP.AU","BK7040","BK7082","RIO.AU","BK7124","SOL.AU","BK7094","BK7511","BK7129"],"gpt_icon":0},{"id":"2531296883","title":"3 ASX 200 stocks to buy and hold forever without thinking twice","url":"https://stock-news.laohu8.com/highlight/detail?id=2531296883","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531296883?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:52","pubTimestamp":1745877144,"startTime":"0","endTime":"0","summary":"When it comes to building lasting wealth, few strategies are as powerful — or as simple — as buy and hold investing. Instead of trying to time the market or jump in and out of ASX 200 stocks based on ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/29/3-asx-200-stocks-to-buy-and-hold-forever-without-thinking-twice/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4588","IE00B19Z3B42.SGD","LU2750360641.GBP","IE0004091025.USD","BK4585","BK7503","LU1868836591.USD","LU2237443978.SGD","BK7067","LU2237443622.USD","BK4127","BK4533","LU0096364046.USD","BK4550","LU2471134952.CNY","LU0742534661.SGD","LU1868836914.USD","WTC.AU","LU2471134523.USD","BK7511","BK4504","IE00B19Z3581.USD","BK4552","LU1791807156.HKD","LU1868837136.USD","LU2237443465.HKD","LU1868837300.USD","LU2237438978.USD","CSL.AU","IE0004086264.USD","LU2471134796.USD","LU2471134879.HKD","LU0106831901.USD","LU1668664300.SGD","LU1868836757.USD","LU2750360997.AUD","BK4516","LU0251131958.USD","BK7508","LU0048573561.USD","IE00BSNM7G36.USD","LU0251142724.SGD","BK7094","PME.AU","IE0002270589.USD","BK7501","LU2237443549.SGD","IE0034235188.USD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2530919288","title":"3 oversold ASX shares begging to rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2530919288","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530919288?lang=en_us&edition=fundamental","pubTime":"2025-04-26 06:35","pubTimestamp":1745620500,"startTime":"0","endTime":"0","summary":"The market has been serving up a fair amount of volatility lately, and in the rush to de-risk portfolios, even some of the highest quality ASX shares have been dragged lower. But as history often show","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/26/3-oversold-asx-shares-begging-to-rebound/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00B19Z3B42.SGD","BK7503","CSL.AU","BK7067","IE0004091025.USD","BK7508","LU0096364046.USD","IE00BSNM7G36.USD","LU1868836757.USD","BK7511","LU1668664300.SGD","BK4504","LU0251142724.SGD","BK4588","LU2237443549.SGD","BK4516","BK4552","LU1868837300.USD","LU2471134879.HKD","LU2750360997.AUD","LU2237443895.HKD","BK7094","LU2471134796.USD","BK4550","LU2750360641.GBP","LU2237443465.HKD","LU1868836591.USD","LU0251131958.USD","PME.AU","BK7501","LU2237443622.USD","LU0106831901.USD","LU0742534661.SGD","LU2471134952.CNY","IE0004086264.USD","BK4585","LU2237443382.USD","LU0061475181.USD","LU1791807156.HKD","IE00BFXG1179.USD","LU2237438978.USD","LU2471134523.USD","IE0002270589.USD","LU2237443978.SGD","BK4127","IE0034235188.USD","LU1868836914.USD","LU1868837136.USD","BK7016","WTC.AU"],"gpt_icon":0},{"id":"2530547992","title":"Warren Buffett's warning to markets played out perfectly: the time to be greedy may be approaching","url":"https://stock-news.laohu8.com/highlight/detail?id=2530547992","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530547992?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:33","pubTimestamp":1745526780,"startTime":"0","endTime":"0","summary":"For long-term investors, periods of volatility often mark the beginning—not the end—of a wealth-building opportunity. Many quality ASX shares, from stalwarts like biotech giant CSL Ltd  and investment bank Macquarie Group Ltd  to fast-growing disruptors like health imaging technology company Pro Medicus Ltd  and online furniture and homewares retailer Temple & Webster Group Ltd , are trading at sharp discounts to what investors were willing to pay just a matter of weeks ago. If you have ve been sitting on the sidelines, waiting for the perfect moment—this may be it. Not because anyone can pick a bottom, but because, as Buffett shows time and again, value appears when investors are being fearful. So, is it time to be greedy?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/25/warren-buffetts-warning-to-markets-played-out-perfectly-the-time-to-be-greedy-may-be-approaching/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0154236417.USD","LU1074936037.SGD","LU0251142724.SGD","LU1363072403.SGD","LU0048573561.USD","BK4585","BK4534","BK7501","IE00B775SV38.USD","LU0417517546.SGD","BK4581","LU0256863811.USD","IE00BKDWB100.SGD","LU1571399168.USD","BRK.B","LU0742534661.SGD","BK7046","BK7094","LU0787776722.HKD","BK4533","IE00B1XK9C88.USD","MQG.AU","BK7511","PME.AU","LU1366333091.USD","LU0149725797.USD","BK7049","BK4550","CSL.AU","LU0640476718.USD","IE00BJLML261.HKD","IE00BK4W5L77.USD","IE00BWXC8680.SGD","LU0251131958.USD","LU0971096721.USD","BK4176","IE0034235303.USD","TPW.AU","IE00B3S45H60.SGD","IE00BK4W5M84.HKD","LU0648001328.SGD","LU0053666078.USD","LU0980610538.SGD","LU0234570918.USD","LU0683600562.USD","BK7508","IE000M9KFDE8.USD","LU0130102774.USD","BK4588","LU0234572021.USD"],"gpt_icon":1},{"id":"2530977299","title":"Telix: A masterclass in what this game is all about","url":"https://stock-news.laohu8.com/highlight/detail?id=2530977299","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530977299?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:16","pubTimestamp":1745525760,"startTime":"0","endTime":"0","summary":"Every now and again, an ASX company emerges that captures the hearts and minds of investors. It doesn't happen every year, but it certainly happens more often than you think. From Droneshield  to ProMedicus  to Supply Network , these companies have all produced total returns in excess of 700% over the last 5 years. The latest market darling is, of course, none other thanTelix Pharmaceuticals. Just 5 years ago, the company reported revenue of $3.5m and now its 2025 sales guidance is in excess of $1.2 billion , a phenomenal 343x increase!Its share price has done alright, just a lazy 25x increase over the same period. It's the stuff that dreams are made of, and it reminds us why we love this game of investing. Now, if you cut out the hype, there are actually important investing lessons to learn from Telix. Stay optimistic and always look forward Five years ago, we were in the midst of a pandemic, and the world was facing a lot of uncertainty. (Not much has changed!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/25/telix-a-masterclass-in-what-this-game-is-all-about/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["TLX.AU","FOMO","BK7115","DRO.AU","BK7086","PME.AU","BK7094","SNL.AU","BK7067"],"gpt_icon":0},{"id":"2529487661","title":"Down 9% in a month! The ASX200 growth stock I'm watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2529487661","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529487661?lang=en_us&edition=fundamental","pubTime":"2025-04-24 05:45","pubTimestamp":1745444700,"startTime":"0","endTime":"0","summary":"PME has dropped significantly from its all time high of almost $300.00 per share back in February. This is despite the fact it has secured key long term contracts with US based companies, and reported strong financial performance. The company's Half Year Results revealed:  Total revenue up 32.15% Underlying EBIT margin increased from 66% to 72% Underlying profit before tax up 42.9% to $69.9 million  I believe its strong position and fundamentals mean it is a growth stock with strong potential. Brokers seem to agree, with Bell Potter placing a price target of $280.00. This would be an upside of 34.18%. Brokers at trading view have a consensus target price of $263.31  and online brokerage platform SelfWealth has an average target price of $261.87.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/24/down-9-in-a-month-the-asx200-growth-stock-im-watching/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","XAO.AU","XJO.AU","BK7094"],"gpt_icon":0},{"id":"2529765770","title":"High Growth Tech Stocks in Australia Including FINEOS Corporation Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2529765770","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529765770?lang=en_us&edition=fundamental","pubTime":"2025-04-24 03:35","pubTimestamp":1745436957,"startTime":"0","endTime":"0","summary":"The Australian market has been experiencing a period of volatility, with recent developments such as Trump's decision to ease tariffs on China contributing to the ASX's movement back towards the 8,000-point mark. In this dynamic environment, high-growth tech stocks like FINEOS Corporation Holdings are attracting attention for their potential resilience and innovation-driven growth amid broader market fluctuations.We're going to check out a few of the best picks from our screener tool.Overview: FINEOS Corporation Holdings plc develops and sells enterprise claims and policy management software for life, accident, and health insurers as well as employee benefits providers across North America, the Asia Pacific, the Middle East, and Africa with a market cap of A$656.72 million.Operations: The company generates revenue primarily from its Software & Programming segment, amounting to 133.22 million. It focuses on providing solutions for claims and policy management tailored to life, accident,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-australia-193557890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7016","XKO.AU","BK7002","FCL.AU","XJO.AU","SEK.AU","BK7094","PME.AU","XAO.AU"],"gpt_icon":0},{"id":"2529593713","title":"2 great ASX growth shares that are much cheaper after the market sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=2529593713","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529593713?lang=en_us&edition=fundamental","pubTime":"2025-04-23 07:47","pubTimestamp":1745365642,"startTime":"0","endTime":"0","summary":"The ASX growth share space is an exciting area to look for opportunities, particularly after the market tariff sell-down, which has led to cheaper valuations.  When businesses are very likely to grow ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/23/2-great-asx-growth-shares-that-are-much-cheaper-after-the-market-sell-off/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XAO.AU","BK7094","PACS","PME.AU","BK7503","BK4185","XKO.AU","XJO.AU","REA.AU","BK7002","EBIT"],"gpt_icon":0},{"id":"2529936293","title":"Down 20% to 40%: These oversold ASX shares could be bargains hiding in plain sight","url":"https://stock-news.laohu8.com/highlight/detail?id=2529936293","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529936293?lang=en_us&edition=fundamental","pubTime":"2025-04-22 09:05","pubTimestamp":1745283953,"startTime":"0","endTime":"0","summary":"The market has taken a beating in recent weeks, and while some of the selling may be justified, there are always a few high-quality ASX shares that get unfairly dragged down with the rest. These are t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/22/down-20-to-40-these-oversold-asx-shares-could-be-bargains-hiding-in-plain-sight/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0267386448.USD","LU1668664300.SGD","LOV.AU","LU0098860793.USD","LU0158827781.USD","LU0912757837.SGD","LU0106261372.USD","LU0158827948.USD","LU1989772840.SGD","LU2111349929.HKD","LU1548497426.USD","BK4534","LU1732799900.SGD","LU0225283273.USD","LU1720051108.HKD","LU1989772923.USD","LU2133065610.SGD","BK4581","BK4585","BK7094","LU0795875169.SGD","LU2089284900.SGD","UNI.AU","LU1162221912.USD","BK4588","BK4127","LU0320765646.SGD","LU1720051017.SGD","IE00BKVL7J92.USD","LU0006306889.USD","LU2089283258.USD","LU1732800096.USD","IE00BZ1G4Q59.USD","LU2347655156.SGD","LU0795875086.SGD","LU0106831901.USD","LU2028103732.USD","PME.AU","LU2271345857.HKD","BK7128","LU1363072403.SGD","LU2357305700.SGD","LU0314104364.USD","BK7021","BK4504","LU0971096721.USD","BK4516","LU2023251221.USD","LU1074936037.SGD"],"gpt_icon":1},{"id":"2529084179","title":"Is Weakness In Pro Medicus Limited (ASX:PME) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529084179","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529084179?lang=en_us&edition=fundamental","pubTime":"2025-04-21 13:58","pubTimestamp":1745215101,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at Pro Medicus'  recent performance, when its stock has declined 21% over the past three months. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. In this article, we decided to focus on Pro Medicus'  ROE.Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.  We check all companies for important risks. See what we found for Pro Medicus in our. Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for Pro Medicus is:. The 'return' is the profit over the last twelve months. So, this means that for every A$1 of its shareholder's investments, the company generates a profit of A$0.44.Besides, Pro Medicus has been paying dividends for at least ten yea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/weakness-pro-medicus-limited-asx-055821535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7094","BK4212","PME.AU","PME"],"gpt_icon":1},{"id":"2528031158","title":"Now could be a golden opportunity to buy these ASX 200 growth shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2528031158","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528031158?lang=en_us&edition=fundamental","pubTime":"2025-04-18 08:44","pubTimestamp":1744937054,"startTime":"0","endTime":"0","summary":"Market volatility may have shaken confidence in recent weeks, but if you're focused on the long term, this could be a golden opportunity to back high-quality businesses with strong growth potential. But which ASX 200 growth shares?A couple that have been attracting bullish calls from top brokers — and offering compelling upside for patient investors, are listed below. Here's why they could be top picks right now: Life360 Inc  Goldman Sachs is feeling bullish about Life360, the location technology company behind one of the most widely used family safety apps in the world. With approximately 80 million users globally, the broker believes the company is sitting on a huge untapped monetisation opportunity. It currently has a buy rating on the ASX 200 growth share with a $27.00 price target. Based on its current share price of $19.70, this implies potential upside of 37% for investors over the next 12 months. What's driving that conviction?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/18/now-could-be-a-golden-opportunity-to-buy-these-asx-200-growth-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","TAM.AU","PME.AU","360.AU","BK7016","BK4023","BK4613","LIF","BK7104"],"gpt_icon":0},{"id":"2528020777","title":"How to build the perfect ASX share portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2528020777","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528020777?lang=en_us&edition=fundamental","pubTime":"2025-04-18 07:08","pubTimestamp":1744931280,"startTime":"0","endTime":"0","summary":"Building a strong ASX share portfolio is one of the best ways to grow long-term wealth. But what does a perfect portfolio look like?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/18/how-to-build-the-perfect-asx-share-portfolio/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7153","CSL.AU","BK7094","BK7099","BK7155","PME.AU","BK7041","BK7046","BK7501","BK7503","WES.AU","BK7508","BK7067","WTC.AU","GMG.AU","BK7016","XRO.AU","IVV.AU","MQG.AU","NDQ.AU","BK7511","BK7510"],"gpt_icon":1},{"id":"2527447668","title":"3 of the best ASX 200 healthcare shares to bring your portfolio to life","url":"https://stock-news.laohu8.com/highlight/detail?id=2527447668","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527447668?lang=en_us&edition=fundamental","pubTime":"2025-04-16 02:00","pubTimestamp":1744740000,"startTime":"0","endTime":"0","summary":"If your portfolio needs a health check, then the healthcare sector could be just what the doctor ordered. ASX 200 healthcare shares have a history of delivering strong, long-term returns thanks to con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/16/3-of-the-best-asx-200-healthcare-shares-to-bring-your-portfolio-to-life/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","LU2471134796.USD","BK7007","LU2750360641.GBP","IE0004086264.USD","LU2237443978.SGD","LU0742534661.SGD","LU1868836757.USD","LU2750360997.AUD","LU0106831901.USD","BK4504","BK4552","BK7508","LU0251142724.SGD","LU2471134879.HKD","BK7067","IE00BSNM7G36.USD","LU1868837300.USD","BK4533","LU2237443549.SGD","LU1868836591.USD","CSL.AU","IE00B19Z3B42.SGD","LU2471134523.USD","RMD.AU","BK4516","BK7501","BK4585","BK7094","IE0034235188.USD","LU2237438978.USD","LU1868837136.USD","LU2237443382.USD","IE0002270589.USD","LU2237443465.HKD","BK7511","LU1668664300.SGD","LU1868836914.USD","LU2237443895.HKD","LU2471134952.CNY","BK4588","IE00B19Z3581.USD","LU2237443622.USD","LU0048573561.USD","BK4550","BK4127","LU1791807156.HKD","IE0004091025.USD","IE00BFXG1179.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2527414054","title":"Shareholders May Not Overlook Pro Medicus Insiders Selling AU$514m In Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2527414054","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527414054?lang=en_us&edition=fundamental","pubTime":"2025-04-15 13:51","pubTimestamp":1744696273,"startTime":"0","endTime":"0","summary":"Last week, Pro Medicus Limited's (ASX:PME) stock jumped 20%, but insiders who sold AU$514m worth of stock in over the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/shareholders-may-not-overlook-pro-medicus-insiders-selling-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2527439482","title":"Pro Medicus inks R&D agreement with UCSF for Visage AI Accelerator","url":"https://stock-news.laohu8.com/highlight/detail?id=2527439482","media":"The Market Herald","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527439482?lang=en_us&edition=fundamental","pubTime":"2025-04-15 12:17","pubTimestamp":1744690620,"startTime":"0","endTime":"0","summary":"Pro Medicus  is strengthening its investment in research and development for imaging product, the Visage AI Accelerator platform in the U.S., signing a multi-year agreement with the University of California San Francisco.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.The agreement – signed between the university and Pro Medicus’ U.S. subsidiary Visage Imaging, Inc. – will provide a framework through which the two parties will collaborate on the development and commercialisation of the platform, looking specifically into its artificial intelligence capabilities.It will also build on a relationship already established with UCSF through an existing agreement related to Pro Medicus’ Visage 7 Viewer product.Visage Imaging Global CTO Malte Westerhoff said the partnership around Visage AI Accelerator was a very important milestone.“Our AI Accelerator program was designed to closely align ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/pro-medicus-inks-rd-agreement-with-ucsf-for-visage-ai-accelerator-2025-04-15/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2527102158","title":"Pro Medicus Unit Signs Multi-Year Research Collaboration Agreement for AI Accelerator Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2527102158","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527102158?lang=en_us&edition=fundamental","pubTime":"2025-04-15 10:48","pubTimestamp":1744685302,"startTime":"0","endTime":"0","summary":"Pro Medicus  said that its wholly-owned US unit, Visage Imaging, signed a multi-year research collaboration agreement with the University of California San Francisco as a framework for collaboration to facilitate the development and commercialization leveraging the Visage AI Accelerator platform, according to a Tuesday Australian bourse filing.The agreement has the potential to develop artificial intelligence products to meet clinical goals and ultimately lead to better patient outcomes, Malte Westerhoff, Visage Imaging's global chief technology officer, said.The research collaboration builds on the existing UCSF Visage 7 Viewer agreement.Pro Medicus' shares fell past 1% in recent trading on Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2527773691","title":"BRIEF-Pro Medicus Signs Multi-Year Research Collaboration Agreement With UCSF","url":"https://stock-news.laohu8.com/highlight/detail?id=2527773691","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527773691?lang=en_us&edition=fundamental","pubTime":"2025-04-15 09:26","pubTimestamp":1744680387,"startTime":"0","endTime":"0","summary":"BRIEF-Pro Medicus Signs Multi-Year Research Collaboration Agreement With UCSFApril 15  - Pro Medicus Ltd PME.AX:DEAL FOR COLLABORATION ON DEVELOPMENT AND COMMERCIALISATION LEVERAGING VISAGE AI ACCELERATOR PLATFORMPME SIGNS MULTI-YEAR RESEARCH COLLABORATION AGREEMENT WITH UCSFFurther company coverage: PME.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS1Z7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2527448711","title":"Pro Medicus shares rise on big AI news","url":"https://stock-news.laohu8.com/highlight/detail?id=2527448711","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527448711?lang=en_us&edition=fundamental","pubTime":"2025-04-15 09:17","pubTimestamp":1744679850,"startTime":"0","endTime":"0","summary":"Pro Medicus Ltd  shares are on the move on Tuesday after the company made a new announcement. At the time of writing, the health imaging technology company's shares are up slightly to $213.50. Why are Pro Medicus shares rising?Investors have been buying the company's shares after it entered into a multi-year research collaboration agreement with the University of California, San Francisco  — one of the most prestigious academic medical centres in the world. The goal?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/15/pro-medicus-shares-rise-on-big-ai-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2527750141","title":"Pro Medicus Ltd - Pme Signs Multi-Year Research Collaboration Agreement With Ucsf","url":"https://stock-news.laohu8.com/highlight/detail?id=2527750141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527750141?lang=en_us&edition=fundamental","pubTime":"2025-04-15 08:31","pubTimestamp":1744677080,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QS1Z7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","PME.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PME.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-27","symbol":"PME.AU","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-28","name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-02-28","currency":"AUD","dateTimestamp":1740574800000,"payDate":"2025-03-21"},{"date":"2025-02-11","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-04","symbol":"PME.AU","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-05","defaultRemindTime":1725408000000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-26","payableDate":"2024-09-05","currency":"AUD","dateTimestamp":1725372000000,"payDate":"2024-09-26"},{"date":"2024-08-14","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723593600000,"name":null,"time":"","dateTimestamp":1723557600000,"actualEps":null},{"date":"2024-02-29","symbol":"PME.AU","amount":0.18,"announcedDate":null,"type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"Pro Medicus Ltd","recordDate":"2024-03-22","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-03-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PME.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-02","value":0.06,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-19","value":0.07,"currency":"AUD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-10-01","value":0.08,"currency":"AUD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-25","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.12,"currency":"AUD"}]}}